← Open Payments lookup

MELINDA BECKNELL: Open Payments

NPI 1841999786 · KENNETT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$969 in 51 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $375 · 2025 $969

Food & beverage: $969
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.8$205
Otsuka America Pharmaceutical, Inc.13$183
Neurocrine BioSciences, Inc.10$177
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$95
Alkermes, Inc.4$87
Janssen Pharmaceuticals, Inc4$74
Vanda Pharmaceuticals Inc.3$58
ABBVIE INC.2$36
E.R. Squibb & Sons, L.L.C.1$24
Lundbeck LLC1$17

Products named: UZEDY, INGREZZA, REXULTI, CAPLYTA, ARISTADA, INVEGA SUSTENNA, ABILIFY MAINTENA, FANAPT.

Industry payments across MO — which companies pay providers there.